Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab
For the treatment of Superficial Femoral Artery
The PP-based top and bottom webs are manufactured in a unique coextrusion process
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Product deliveries scheduled in Q3 of 2023
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Farxiga is expected to have such a strong influence on the market due to the impressive results
Subscribe To Our Newsletter & Stay Updated
